MedTrace Logo

Cancellous Bone Autograft, Bone Substitute, Local Antibiotic, and Fresh Blood for Ununited Fixed Femoral and Tibial Fractures

NCT07561788 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2026-05-01

No results posted yet for this study

Summary

This study aimed to assess the clinical and radiological outcomes of the usage of autogenous bone graft mixed with bone substitute, fresh blood of patient and local antibiotic used as an onlay graft in treatment of nonunion or delayed union of fixed femoral and tibia fractures.

Conditions

  • Cancellous Bone Autograft
  • Bone Substitute
  • Local Antibiotic
  • Fresh Blood
  • Ununited Fixed Femoral and Tibial Fractures

Interventions

PROCEDURE

Revision using a composite graft

All patients underwent revision using a composite graft and either retained intramedullary nails or Ilizarov fixators.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-10-01
Completion
2024-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07561788 on ClinicalTrials.gov